...
首页> 外文期刊>Breast care >A Case Report of Triple-Positive Micropapillary Carcinoma of the Male Breast
【24h】

A Case Report of Triple-Positive Micropapillary Carcinoma of the Male Breast

机译:男性乳腺癌三阳性微乳头状癌1例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Micropapillary carcinoma (MPC), a morphologically distinct subtype of invasive ductal carcinoma, of the male breast is an exceedingly uncommon disease. Case Report Herein, we report a case of triple-positive MPC of the male breast with axillary lymph node involvement and no recurrence for over 2 years. Specifically, a 60-year-old male patient presented with a hard, elastic, and well-defined painless mass in the right breast. The patient underwent unilateral (right) modified radical mastectomy with axillary clearance. Histopathology revealed MPC grade 3 and metastasis in 16/16 lymph nodes. Hormone receptor analysis demonstrated strong positivity (total score 08) for estrogen/progesterone receptors and overexpression (score 3+) of human epidermal growth factor receptor 2. The patient received adjuvant chemotherapy (6 courses of CAF cyclophosphamide, doxorubicin, and 5-fluorouracil), radiation, and tamoxifen. The patient has remained disease-free for over 2 years. Conclusion This study demonstrates that triple-positive MPC of the male breast as a rare malignancy appears to respond promisingly to multimodality treatment.
机译:背景技术男性乳腺微乳头状癌(MPC)是浸润性导管癌的形态学上独特的亚型,是一种极为罕见的疾病。病例报告在此,我们报告了一名男性腋窝淋巴结受累且三周阳性的MPC病例,在过去2年中均未复发。具体来说,一名60岁的男性患者右乳房出现坚硬,有弹性且轮廓分明的无痛肿块。该患者接受了单侧(右)改良根治性乳房切除术,并清除了腋窝。组织病理学显示MPC 3级和16/16淋巴结转移。激素受体分析显示出对雌激素/孕激素受体的强阳性(总分08)和人表皮生长因子受体2的过表达(3分以上)。患者接受了辅助化疗(6个疗程的CAF环磷酰胺,阿霉素和5-氟尿嘧啶) ,辐射和他莫昔芬。该患者无病已超过2年。结论这项研究表明,男性乳腺癌的三阳性MPC作为一种罕见的恶性肿瘤,似乎有望对多模式治疗做出反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号